Stay updated on Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.

Latest updates to the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 banner; removed Revision: v3.4.1 notice and a government funding lapse notice. These are maintenance updates and do not affect the trial details, eligibility criteria, or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding/status notice and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedA new 'Show glossary' option is added, and several metadata labels and the revision text were updated (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page; this appears to be a minor version update that does not affect study content or functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter update: Revision: v3.3.3 has been added. The previous Revision: v3.3.2 text and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.1%

- Check91 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.